Xavier Preville

Dr. Xavier Preville is the co-founder and Chief Scientific Officer of Emergence Therapeutics. He previously served as Chief Scientific Officer at Talix Therapeutics and worked for Transgene, where he was responsible for managing the pre-clinical development of various immuno-therapeutics including viral therapeutic vaccines, oncolytic viruses and monoclonal antibodies. Dr. Preville previously worked for BT Pharma (now Genticel), where he successfully led the pre-clinical development and production team. Dr Preville is a cellular immunologist by trade, with more than 15 years industrial experience. He holds a PhD in cellular biology from the Claude Bernard Lyon I University.